Geneos Wealth Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-65
Closed -$690 2068
2024
Q1
$690 Buy
+65
New +$568 ﹤0.01% 2087
2022
Q4
Sell
-356
Closed -$2K 2024
2022
Q3
$2K Sell
356
-192
-35% -$1.33K ﹤0.01% 1821
2022
Q2
$4K Hold
548
﹤0.01% 2238
2022
Q1
$12K Hold
548
﹤0.01% 1997
2021
Q4
$15K Sell
548
-50
-8% -$1.34K ﹤0.01% 2009
2021
Q3
$17K Hold
598
﹤0.01% 1990
2021
Q2
$17K Buy
598
+50
+9% +$1.51K ﹤0.01% 1983
2021
Q1
$17K Hold
548
﹤0.01% 2145
2020
Q4
$16K Sell
548
-550
-50% -$10.3K ﹤0.01% 2021
2020
Q3
$16K Sell
1,098
-500
-31% -$8.61K ﹤0.01% 1747
2020
Q2
$29K Hold
1,598
﹤0.01% 1451
2020
Q1
$23K Sell
1,598
-157
-9% -$3.79K ﹤0.01% 1442
2019
Q4
$52K Hold
1,755
﹤0.01% 1226
2019
Q3
$38K Buy
1,755
+36
+2% +$824 ﹤0.01% 1309
2019
Q2
$43K Sell
1,719
-150
-8% -$3.56K ﹤0.01% 1266
2019
Q1
$46K Hold
1,869
﹤0.01% 1183
2018
Q4
$35K Sell
1,869
-544
-23% -$12.9K ﹤0.01% 1258
2018
Q3
$61K Buy
+2,413
New +$55.3K ﹤0.01% 1077

Other funds holding BHC

Geneos Wealth Management's BHC Position: Q2 2024 in Review

Geneos Wealth Management sold out of Bausch Health (BHC) in Q2 2024, closing a stake of 65 shares — an estimated $690 sold.

Geneos Wealth Management first reported a position in BHC in Q3 2018 and held it in 18 quarters. The position peaked at $61K in Q3 2018. 234 funds tracked by Wall St. Rank hold BHC as of Q2 2024.

  • Geneos Wealth Management reported no remaining Bausch Health position as of Q2 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 65 Bausch Health shares in Q2 2024, an estimated $690.
  • Geneos Wealth Management first reported a position in Bausch Health in Q3 2018 and held it in 18 quarters.
  • Geneos Wealth Management's Bausch Health position peaked at $61K in Q3 2018.
  • 234 funds tracked by Wall St. Rank held Bausch Health as of Q2 2024.

Based on Geneos Wealth Management's 13F filing for Q2 2024, filed 23 Jul 2024.